The expression of MIR-125b-5p is increased in the serum of patients with chronic hepatitis B infection and inhibits the detection of hepatitis B virus surface antigen

Journal of Viral Hepatitis

Volumn 23, Issue 5, 2016, Pages 330-339

  Ninomiya, M ^a   Kondo, Y ^a,b   Kimura, O ^a   Funayama, R ^c   Nagashima, T ^c   Kogure, T ^a   Morosawa, T ^a   Tanaka, Y ^d   Nakayama, K ^c   Shimosegawa, T ^a  

^a TOHOKU UNIVERSITY HOSPITAL   (Japan)

^b SENDAI KOUSEI HOSPITAL   (Japan)

^c TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

Author keywords

deep sequencing; hepatitis B virus; luciferase reporter assay; MicroRNAs; MIR 125b 5p

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; MICRORNA; MICRORNA 100 5P; MICRORNA 125B 5P; MICRORNA 193B 3P; MICRORNA 194 3P; MICRORNA 30A 3P; MICRORNA 30C 2 3P; MICRORNA 3591 5P; MICRORNA 4709 3P; MICRORNA 574 3P; MICRORNA 99A 5P; OLIGONUCLEOTIDE; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; MIRN125 MICRORNA, HUMAN;

ANTIGEN DETECTION; ARTICLE; CHRONIC HEPATITIS B; CLINICAL ARTICLE; COMPUTER ANALYSIS; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE LIBRARY; GENETIC TRANSFECTION; GENOMICS; HEPATITIS B VIRUS; HEPATITIS B VIRUS GENOTYPE B; HEPATITIS B VIRUS GENOTYPE C; HUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REPORTER GENE; SERUM; BIOSYNTHESIS; BLOOD; IMMUNOLOGY; PATHOLOGY; UPREGULATION; VIROLOGY;

BIOMARKERS; DOWN-REGULATION; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; MICRORNAS; REAL-TIME POLYMERASE CHAIN REACTION; SERUM; UP-REGULATION;

EID: 84959270484     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/jvh.12522     Document Type: Article

References (46)

1. Zuckerman AJ,. Hepatitis Viruses. 1996.
2. Maddrey WC,. Hepatitis B: an important public health issue. J Med Virol 2000; 61 (3): 362-366.
3. Zuckerman JN, Zuckerman AJ,. Current topics in hepatitis B. J Infect 2000; 41 (2): 130-136.
4. Kao JH, Chen DS,. Global control of hepatitis B virus infection. Lancet Infect Dis 2002; 2 (7): 395-403.
5. Lee RC, Feinbaum RL, Ambros V,. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 1993; 75 (5): 843-854.
6. Griffiths-Jones S, Grocock RJ, van Dongen S, Bateman A, Enright AJ,. miRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Res 2006; 34 (Database issue): D140-D144.
7. Ghosh Z, Mallick B, Chakrabarti J,. Cellular versus viral microRNAs in host-virus interaction. Nucleic Acids Res 2009; 37 (4): 1035-1048.
8. Lagos-Quintana M, Rauhut R, Lendeckel W, Tuschl T,. Identification of novel genes coding for small expressed RNAs. Science 2001; 294 (5543): 853-858.
9. Bartel DP,. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004; 116 (2): 281-297.
10. Kann M, Bischof A, Gerlich WH,. In vitro model for the nuclear transport of the hepadnavirus genome. J Virol 1997; 71 (2): 1310-1316.
11. Locarnini S,. Molecular virology of hepatitis B virus. Semin Liver Dis 2004; 24 (Suppl. 1): 3-10.
12. Jopling CL, Yi M, Lancaster AM, Lemon SM, Sarnow P,. Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA. Science 2005; 309 (5740): 1577-1581.
13. Pedersen IM, Cheng G, Wieland S, et al,. Interferon modulation of cellular microRNAs as an antiviral mechanism. Nature 2007; 449 (7164): 919-922.
14. Ji F, Yang B, Peng X, Ding H, You H, Tien P,. Circulating microRNAs in hepatitis B virus-infected patients. J Viral Hepat 2011; 18 (7): e242-e251.
15. Qiu L, Fan H, Jin W, et al,. miR-122-induced down-regulation of HO-1 negatively affects miR-122-mediated suppression of HBV. Biochem Biophys Res Commun 2010; 398 (4): 771-777.
16. Zhang GL, Li YX, Zheng SQ, Liu M, Li X, Tang H,. Suppression of hepatitis B virus replication by microRNA-199a-3p and microRNA-210. Antiviral Res 2010; 88 (2): 169-175.
17. Potenza N, Papa U, Mosca N, Zerbini F, Nobile V, Russo A,. Human microRNA hsa-miR-125a-5p interferes with expression of hepatitis B virus surface antigen. Nucleic Acids Res 2011; 39 (12): 5157-5163.
18. Waidmann O, Bihrer V, Pleli T, et al,. Serum microRNA-122 levels in different groups of patients with chronic hepatitis B virus infection. J Viral Hepat 2012; 19 (2): e58-e65.
19. Ura S, Honda M, Yamashita T, et al,. Differential microRNA expression between hepatitis B and hepatitis C leading disease progression to hepatocellular carcinoma. Hepatology 2009; 49 (4): 1098-1112.
20. Tomimaru Y, Eguchi H, Nagano H, et al,. Circulating microRNA-21 as a novel biomarker for hepatocellular carcinoma. J Hepatol 2012; 56 (1): 167-175.
21. Lok ASF, McMahon BJ,. Chronic hepatitis B. Hepatology 2007; 45 (2): 507-539.
22. Ghany MG, Strader DB, Thomas DL, Seeff LB,. American association for the study of liver D. Diagnosis, management, and treatment of hepatitis C: an update. Hepatology 2009; 49 (4): 1335-1374.
23. Lindor KD, Gershwin ME, Poupon R, Kaplan M, Bergasa NV, Heathcote EJ,. Primary biliary cirrhosis. Hepatology 2009; 50 (1): 291-308.
24. Ninomiya M, Kondo Y, Funayama R, et al,. Distinct microRNAs expression profile in primary biliary cirrhosis and evaluation of miR 505-3p and miR197-3p as novel biomarkers. PLoS ONE 2013; 8 (6): e66086.
25. Martin M,. Cutadapt removes adapter sequences from high-throughput sequencing reads. EMBnet J 2011; 17 (1): 10-12.
26. Maglott D, Ostell J, Pruitt KD, Tatusova T,. Entrez Gene: gene-centered information at NCBI. Nucleic Acids Res 2010; 39 (Database): D52-D57.
27. Kozomara A, Griffiths-Jones S,. miRBase: integrating microRNA annotation and deep-sequencing data. Nucleic Acids Res 2010; 39 (Database): D152-D157.
28. Robinson MD, Oshlack A,. A scaling normalization method for differential expression analysis of RNA-seq data. Genome Biol 2010; 11 (3): R25.
29. Benjamini Y, Hochberg Y,. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Roy Stat Soc 1995; 57 (1): 289-300.
30. Team RDC. R: A Language and Environment for Statistical Computing. Vienna, Austria: the R Foundation for Statistical Computing, 2011.
31. Mitchell PS, Parkin RK, Kroh EM, et al,. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci 2008; 105 (30): 10513-10518.
32. Kruger J, Rehmsmeier M,. RNAhybrid: microRNA target prediction easy, fast and flexible. Nucleic Acids Res 2006; 34 (Web Server issue): W451-W454.
33. Pult I, Chouard T, Wieland S, Klemenz R, Yaniv M, Blum HE,. A hepatitis B virus mutant with a new hepatocyte nuclear factor 1 binding site emerging in transplant-transmitted fulminant hepatitis B. Hepatology 1997; 25 (6): 1507-1515.
34. Takahashi K, Akahane Y, Hino K, Ohta Y, Mishiro S,. Hepatitis B virus genomic sequence in the circulation of hepatocellular carcinoma patients: comparative analysis of 40 full-length isolates. Arch Virol 1998; 143 (12): 2313-2326.
35. Lewis BP, Burge CG, Bartel DP,. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell. 2005; 120 (1): 15-20.
36. Grimson A, Farh KK, Johnston WK, Garrett-Engele P, Lim LP, Bartel DP,. MicroRNA targeting specificity in mammals: determinants beyond seed pairing. Mol Cell. 2007; 27 (1): 91-105.
37. Garcia DM, Baek D, Shin C, Bell GW, Grimson A, Bartel DP,. Weak seed-pairing stability and high target-site abundance decrease the proficiency of lsy-6 and other microRNAs. Nat Struct Mol Biol. 2011; 18 (10): 1139-1146.
38. Sugiyama M, Tanaka Y, Kato T, et al,. Influence of hepatitis B virus genotypes on the intra- and extracellular expression of viral DNA and antigens. Hepatology. 2006; 44 (4): 915-924.
39. Duan Z, Chen X, Liang Z, et al,. Genetic polymorphisms of CXCR5 and CXCL13 are associated with non-responsiveness to the hepatitis B vaccine. Vaccine. 2014; 32 (41): 5316-5322.
40. Lambert C, Doring T, Prange R,. Hepatitis B virus maturation is sensitive to functional inhibition of ESCRT-III, Vps4, and gamma 2-adaptin. J Virol. 2007; 81 (17): 9050-9060.
41. Watanabe T, Sorensen EM, Naito A, Schott M, Kim S, Ahlquist P,. Involvement of host cellular multivesicular body functions in hepatitis B virus budding. Proc Natl Acad Sci U S A. 2007; 104 (24): 10205-10210.
42. Ahmadabadi BN, Hassanshahi G, Khoramdelazad H, et al,. Downregulation of CCR5 expression on the peripheral blood CD8 + T cells of southeastern Iranian patients with chronic hepatitis B infection. Inflammation. 2013; 36 (1): 136-140.
43. Schwarzenbach H, Nishida N, Calin GA, Pantel K,. Clinical relevance of circulating cell-free microRNAs in cancer. Nat Rev Clin Oncol 2014; 11 (3): 145-156.
44. Caby MP, Lankar D, Vincendeau-Scherrer C, Raposo G, Bonnerot C,. Exosomal-like vesicles are present in human blood plasma. Int Immunol 2005; 17 (7): 879-887.
45. Valadi H, Ekstrom K, Bossios A, Sjostrand M, Lee JJ, Lotvall JO,. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 2007; 9 (6): 654-659.
46. Zhang Z, Chen J, He Y, et al,. miR-125b inhibits hepatitis B virus expression in vitro through targeting of the SCNN1A gene. Arch Virol 2014; 159 (12): 3335-3343.